Bharat Parenterals reports consolidated net loss of Rs 7.51 crore in the September 2024 quarter

Net loss of Bharat Parenterals reported to Rs 7.51 crore in the quarter ended September 2024 as against net profit of Rs 3.52 crore during the previous quarter ended September 2023. Sales rose 19.76% to Rs 71.63 crore in the quarter ended September 2024 as against Rs 59.81 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	71.63	59.81	20
OPM %	-10.69	7.22	-
PBDT	-6.36	6.29	PL
PBT	-15.37	4.54	PL
NP	-7.51	3.52	PL